What adverse reactions happened during this study?
The most common adverse reaction was redness at the site of the injection.
The table below shows the adverse reactions that happened in 0.5% or more
of participants during the study. There were other adverse reactions but these
happened in fewer participants.
Most common adverse reactions
Tezepelumab Placebo
Adverse reaction (out of 528 participants) (out of 531 participants)
Injection site redness 1.5% (8) 1.9% (10)
Headache 1.5% (8) 0.9% (5)
Fatigue 0.9% (5) 0.8% (4)
Injection site pain 0.9% (5) 0.8% (4)
Injection site swelling 0.8% (4) 0.2% (1)
Pain in a joint 0.8% (4) 0.2% (1)
Lack of energy 0.6% (3) 0.4% (2)
Rash 0.0% (0) 0.6% (3)
How has this study helped patients and
researchers?
This study helped researchers learn more about how tezepelumab works and
about its safety in participants with severe asthma.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this 1 study.
Other studies may provide new information or different results.
Further clinical studies with tezepelumab are planned.
14 | Clinical Study Results